Clinical Trial Update: Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents [NA]

View source ↗

Summary

This clinical trial update reports tolerability and immunogenicity data for the FLUVAL P H1N1 influenza vaccine in children and adolescents; the study is marked…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Virus Subtype H1n1

Drugs mentioned

• FLUVAL P H1N1 Flu Vaccine (Influenza vaccine)

Snippet

Sponsor: Fluart Innovative Vaccine Ltd, Hungary | Conditions: Novel 2009 Influenza H1N1, Influenza, Human | NA | Status: COMPLETED